Sanofi (NASDAQ:SNY) Shares Bought by Jones Financial Companies Lllp

Jones Financial Companies Lllp grew its holdings in Sanofi (NASDAQ:SNY) by 55.0% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,122 shares of the company’s stock after acquiring an additional 5,366 shares during the quarter. Jones Financial Companies Lllp’s holdings in Sanofi were worth $729,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of SNY. Franklin Resources Inc. boosted its position in Sanofi by 13.1% in the third quarter. Franklin Resources Inc. now owns 3,407,452 shares of the company’s stock valued at $208,106,000 after buying an additional 395,744 shares during the last quarter. Natixis Advisors LLC boosted its holdings in Sanofi by 4.1% during the third quarter. Natixis Advisors LLC now owns 2,874,193 shares of the company’s stock worth $165,640,000 after buying an additional 114,133 shares in the last quarter. JPMorgan Chase & Co. grew its position in Sanofi by 20.9% during the third quarter. JPMorgan Chase & Co. now owns 2,310,809 shares of the company’s stock valued at $133,172,000 after buying an additional 399,301 shares during the period. DAVENPORT & Co LLC increased its holdings in Sanofi by 40.7% in the fourth quarter. DAVENPORT & Co LLC now owns 2,295,569 shares of the company’s stock valued at $110,715,000 after buying an additional 664,455 shares in the last quarter. Finally, Jennison Associates LLC increased its stake in shares of Sanofi by 938.0% in the 3rd quarter. Jennison Associates LLC now owns 1,904,445 shares of the company’s stock valued at $109,753,000 after purchasing an additional 1,720,972 shares in the last quarter. Hedge funds and other institutional investors own 14.04% of the company’s stock.

Sanofi Stock Down 0.3 %

Sanofi stock opened at $59.25 on Monday. Sanofi has a fifty-two week low of $45.22 and a fifty-two week high of $59.72. The firm has a 50 day moving average price of $52.65 and a 200 day moving average price of $52.73. The company has a market capitalization of $150.37 billion, a PE ratio of 23.80, a price-to-earnings-growth ratio of 1.01 and a beta of 0.58. The company has a debt-to-equity ratio of 0.15, a quick ratio of 1.14 and a current ratio of 1.46.

Sanofi (NASDAQ:SNY) last posted its quarterly earnings data on Thursday, January 30th. The company reported $0.70 EPS for the quarter, meeting the consensus estimate of $0.70. Sanofi had a net margin of 12.77% and a return on equity of 25.61%. Research analysts expect that Sanofi will post 4.36 earnings per share for the current year.

Analysts Set New Price Targets

A number of research firms have weighed in on SNY. Deutsche Bank Aktiengesellschaft upgraded shares of Sanofi from a “sell” rating to a “hold” rating in a research report on Thursday, January 30th. StockNews.com downgraded Sanofi from a “buy” rating to a “hold” rating in a research report on Thursday, December 12th. Finally, Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a report on Thursday, January 30th. Two equities research analysts have rated the stock with a hold rating, one has issued a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Sanofi presently has a consensus rating of “Buy” and an average price target of $60.00.

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products.